CannPal Animal Therapeutics Limited

The Company has a research focus on cannabinoids, the active pharmaceutical ingredients extracted from the cannabis plant, to provide veterinarians and pet owners with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.

CannPal has identified a significant opportunity to benefit from the rapidly growing medical cannabis and animal health markets by developing innovate therapeutics that can influence the Endocannabinoid System with full regulatory approval for veterinary distribution.

To provide veterinarians and pet owners with innovative and naturally derived therapeutics to treat pets in a safe and ethical way

To be a global leader in the development of therapeutic products for companion animals using plant compounds that influence the endocannabinoid system > (scope grows);